Rapid molecular detection of tuberculosis [3]

New England Journal of Medicine

Volumn 364, Issue 2, 2011, Pages 183-

  Bhanot, Nitin ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; HUMAN; LETTER; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 78651361227     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Ridzon R, Whitney CG, McKenna MT, et al. Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med 1998;157:1881-4.
2. Lutfey M, Della-Latta P, Kapur V, et al. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med 1996;153:837-40.
3. Malhotra S, Cook VJ, Wolfe JN, Tang P, Elwood K, Sharma MK. A mutation in Mycobacterium tuberculosis rpoB gene confers rifampin resistance in three HIV-TB cases. Tuberculosis (Edinb) 2010;90:152-7.
4. Francis J. Curry National Tuberculosis Center, California Department of Public Health. Drug-resistant tuberculosis: a survival guide for clinicians. 2nd ed. 2008. (http://www.nationaltbcenter.ucsf.edu/drtb.)